Alterations in activity-regulated inhibitor of death gene expression in spinocerebellar ataxia type 2 and type 3Inês Afonso, David V. C. Brito, Hilmar Bading, Clévio Nóbrega
CRISPR-mediated approaches for ATXN2 knockdown in SCA2 models of diseaseRebekah Koppenol, Luís Pereira de Almeida, Carlos A Matos, Clévio Nóbrega
Mechanisms of spinocerebellar ataxia type 2 pathogenesis: Insights from small extracellular vesiclesRafael Costa, Jéssica Martins, Adriana Vaz et al.
NMDAR-TRPM4 coupling drives neurotoxicity and disease progression in models of spinocerebellar ataxiasDavid Brito, Inês Afonso, Sofia Calado et al.
Stress granules: How they impact spinocerebellar ataxia type 2?André Conceição, Filipa Couto, David Brito et al.